Dunn RL - Search Results

1

Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.

Smith DC, Chay CH, Dunn RL, Fardig J, Esper P, Olson K, Pienta KJ. Smith DC, et al. Among authors: dunn rl. Cancer. 2003 Jul 15;98(2):269-76. doi: 10.1002/cncr.11494. Cancer. 2003. PMID: 12872344 Free article. Clinical Trial.

2

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Smith DC, et al. Among authors: dunn rl. J Clin Oncol. 1998 May;16(5):1835-43. doi: 10.1200/JCO.1998.16.5.1835. J Clin Oncol. 1998. PMID: 9586898 Clinical Trial.

3

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy.

Sandler HM, Dunn RL, McLaughlin PW, Hayman JA, Sullivan MA, Taylor JM. Sandler HM, et al. Among authors: dunn rl. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):629-33. doi: 10.1016/s0360-3016(00)00717-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020557

4

Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.

Miller DC, Litwin MS, Sanda MG, Montie JE, Dunn RL, Resh J, Sandler H, Wei JT. Miller DC, et al. Among authors: dunn rl. Cancer. 2003 Mar 15;97(6):1428-35. doi: 10.1002/cncr.11216. Cancer. 2003. PMID: 12627506 Free article.

5

Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.

Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. Redman BG, et al. Among authors: dunn rl. Clin Cancer Res. 2003 May;9(5):1666-72. Clin Cancer Res. 2003. PMID: 12738719 Clinical Trial.

6

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Fu Z, et al. Among authors: dunn rl. J Natl Cancer Inst. 2003 Jun 18;95(12):878-89. doi: 10.1093/jnci/95.12.878. J Natl Cancer Inst. 2003. PMID: 12813171

7

Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.

Miller DC, Zheng SL, Dunn RL, Sarma AV, Montie JE, Lange EM, Meyers DA, Xu J, Cooney KA. Miller DC, et al. Among authors: dunn rl. Cancer Res. 2003 Jul 1;63(13):3486-9. Cancer Res. 2003. PMID: 12839931

8

Family history of prostate cancer and relapse after definitive external beam radiation therapy.

Ray ME, Dunn RL, Cooney KA, Sandler HM. Ray ME, et al. Among authors: dunn rl. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):371-6. doi: 10.1016/s0360-3016(03)00504-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957247

9

In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice.

Kalikin LM, Schneider A, Thakur MA, Fridman Y, Griffin LB, Dunn RL, Rosol TJ, Shah RB, Rehemtulla A, McCauley LK, Pienta KJ. Kalikin LM, et al. Among authors: dunn rl. Cancer Biol Ther. 2003 Nov-Dec;2(6):656-60. Cancer Biol Ther. 2003. PMID: 14688471

10

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ. Chen BT, et al. Among authors: dunn rl. Urology. 2005 Mar;65(3):616-21. doi: 10.1016/j.urology.2004.10.053. Urology. 2005. PMID: 15780403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters